The coagulopathy of cardiopulmonary bypass

References

• Oberman HA. The indications for transfusion of freshly drawn blood. JAMA 1967; 199: 93–97.
   Google Scholar
• Zuhdi N, McCollough B, Carey J, Greer A. Double-belical reservoir heart-lung machine designed for hypothermic perfusion; primed with 5 per cent glucose in water; inducing hemodilution. Arch Surg 1961; 82: 320–325.
   Google Scholar
• Jones RE, Donald DE, Swan HJ, Harshbarger HG, Kirklin JW, Wood EH. Apparatus of the gibbon type for mechanical bypass of the heart and lungs; preliminary report. Proc Staff Meet Mayo Clin 1955; 30: 105–113.
   Google Scholar
• Lillehei CW. Historical development of cardiopulmonary bypass in Minnesota. In Gravlee PG, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Edi. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: p. 3–21.
   Google Scholar
• Bull BS, Hay KL, Herrmann PC. Postoperative bypass bleeding: a bypass-associated dilutional (bad) coagulopathy? Blood Cells Mol Dis 2009; 43: 256–259.
   Google Scholar
• Stammers AH, Trowbridge CC. Principles of oxygenator function: gas exchange, heat transfer, and operation. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: 47–63.
   Google Scholar
• De Somer FMJJ, Van Nooten G. Blood pumps in cardiopulmonary bypass. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: 35–46.
   Google Scholar
• Schonberger JP, Everts PA, Hoffmann JJ. Systemic blood activation with open and closed venous reservoirs. Ann Thorac Surg 1995; 59: 1549–1555.
   Google Scholar
• Innerhofer P, Wiedermann FJ, Tiefenthaler W, Schobersberger W, Klingler A, Velik-Salchner C, Oswald E, Salner E, Irschick E, Kuhbacher G. Are leukocytes in salvaged washed autologous blood harmful for the recipient? The results of a pilot study. Anesth Analg 2001; 93: 566–572.
   PubMedGoogle Scholar
• Slater MS, Komanapalli CB, Song H. Myocardial protection. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: 47–63.
   Google Scholar
• Westaby S. Coagulation disturbance in profound hypothermia: the influence of anti-fibrinolytic therapy. Semin Thorac Cardiovasc Surg 1997; 9: 246–256.
   Google Scholar
• Edmunds LHJr. Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8: 404–410.
   Google Scholar
• Vogler EA, Siedlecki CA. Contact activation of blood plasma coagulation. Biomaterials 2009; 30: 1857–1869.
   PubMed Web of Science ®Google Scholar
• Kincaid EH, Jones TJ, Stump DA, Brown WR, Moody DM, Deal DD, Hammon JWJr. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg 2000; 70: 1296–1300.
   PubMed Web of Science ®Google Scholar
• Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LHJr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93: 2014–2018.
   PubMedGoogle Scholar
• Brooker RF, Brown WR, Moody DM, Hammon JWJr, Reboussin DM, Deal DD, Ghazi-Birry HS, Stump DA. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998; 65: 1651–1655.
   PubMed Web of Science ®Google Scholar
• Edmunds LHJr, Saxena NC, Hillyer P, Wilson TJ. Relationship between platelet count and cardiotomy suction return. Ann Thorac Surg 1978; 25: 306–310.
   PubMedGoogle Scholar
• Boldt J, Knothe C, Welters I, Dapper FL, Hempelmann G. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ? Ann Thorac Surg 1996; 62: 130–135.
   PubMed Web of Science ®Google Scholar
• Shore-Lesserson L, Gravlee P. Anticoagulation for cardiopulmonary bypass. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: 472–501.
   Google Scholar
• Chandler WL, Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 2003; 101: 4355–4362.
   Google Scholar
• Edmunds LH. Managing fibrinolysis without aprotinin. Ann Thorac Surg 2010; 89: 324–331.
   Google Scholar
• Hope AF, Heyns AD, Lotter MG, van Reenen OR, de Kock F, Badenhorst PN, Pieters H, Kotze H, Meyer JM, Minnaar PC. Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 880–886.
   PubMed Web of Science ®Google Scholar
• McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M. The hemostatic mechanism after open-heart surgery. Ii. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 298–308.
   PubMedGoogle Scholar
• Umlas J. In vivo platelet function following cardiopulmonary bypass. Transfusion 1975; 15: 596–599.
   Google Scholar
• Tamari Y, Aledort L, Puszkin E, Degnan TJ, Wagner N, Kaplitt MJ, Peirce EC 2d. Functional changes in platelets during extracorporeal circulation. Ann Thorac Surg 1975; 19: 639–647.
   Google Scholar
• Hyde JA, Chinn JA, Graham TR. Platelets and cardiopulmonary bypass. Perfusion 1998; 13: 389–407.
   PubMedGoogle Scholar
• Suzuki Y, Hillyer P, Miyamoto S, Niewiarowski S, Sun L, Rao AK, Hollenbach S, Edmunds LHJr. Integrilin prevents prolonged bleeding times after cardiopulmonary bypass. Ann Thorac Surg 1998; 66: 373–381.
   Google Scholar
• Chargaff E. The occurrence in mammalian tissue of a lipid fraction acting as inhibitor of blood clotting. Science 1937; 85: 548–549.
   Google Scholar
• Rothnie NG, Kinmonth JB. Bleeding after perfusion for open heart surgery. Importance of unneutralized heparin and its proper correction. Br Med J 1960; 1: 73–78.
   Google Scholar
• Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. Ii. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975; 69: 685–689.
   PubMed Web of Science ®Google Scholar
• Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975; 69: 674–684.
   PubMed Web of Science ®Google Scholar
• Bull MH, Huse WM, Bull BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anesthesiology 1975; 43: 346–353.
   PubMed Web of Science ®Google Scholar
• Young JA, Kisker CT, Doty DB. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg 1978; 26: 231–240.
   PubMed Web of Science ®Google Scholar
• Despotis GJ, Joist JH, Goodnough LT, Santoro SA, Spitznagel E. Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-xa measurements. J Thorac Cardiovasc Surg 1997; 113: 611–613.
   Google Scholar
• Shirota K, Watanabe T, Takagi Y, Ohara Y, Usui A, Yasuura K. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass. Artif Organs 2000; 24: 49–56.
   Google Scholar
• Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999; 91: 1122–1151.
   PubMed Web of Science ®Google Scholar
• Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth 1998; 45: 10–18.
   Google Scholar
• van Veen JJ, Laidlaw S, Swanevelder J, Harvey N, Watson C, Kitchen S, Makris M. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin. Eur J Haematol 2009; 82: 208–212.
   PubMed Web of Science ®Google Scholar
• Hartert H. Die thrombelastographie. Eine methode zur physikalischen analyse des blutgerinnungsvorganges. Zeitschrift fdgesexperMed 1951; 117: 189.
   Google Scholar
• Von Kaulla KN, Weiner M. Studies of coagulation and fibrinolysis by new technic of continuous recording. Blood 1955; 10: 362–369.
   Google Scholar
• Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168–173.
   PubMed Web of Science ®Google Scholar
• Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575–578.
   PubMed Web of Science ®Google Scholar
• Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19: 212–219.
   PubMed Web of Science ®Google Scholar
• Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009; 138: 694–702.
   PubMed Web of Science ®Google Scholar
• Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81–90.
   PubMedGoogle Scholar
• Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104: 555–562.
   PubMed Web of Science ®Google Scholar
• Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981; 46: 752–756.
   PubMed Web of Science ®Google Scholar
• Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312–319.
   PubMed Web of Science ®Google Scholar
• Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94: 773–781.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102: 137–144.
   PubMed Web of Science ®Google Scholar
• Korte WC, Szadkowski C, Gahler A, Gabi K, Kownacki E, Eder M, Degiacomi P, Zoller N, Devay J, Lange J, Schnider T. Factor xiii substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110: 239–245.
   PubMed Web of Science ®Google Scholar
• Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 1989; 37: 158–162.
   Google Scholar
• Gelb AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW, Cloutier M, Verrier E, Mangano DT. Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. Am J Clin Pathol 1996; 106: 87–99.
   PubMed Web of Science ®Google Scholar
• MacLennan S, Murphy MF. Survey of the use of whole blood in current blood transfusion practice. Clin Lab Haematol. 2001; 23: 391–396.
   Google Scholar
• Dewall RA, Long DM, Gemmill SJ, Lillehei CW. Certain blood changes in patients undergoing extracorporeal circulation; analysis of 350 perfusions. J Thorac Surg 1959; 37: 325–333.
   Google Scholar
• Salzman EW. Blood platelets and extracorporeal circulation. Transfusion 1963; 3: 274–277.
   PubMed Web of Science ®Google Scholar
• Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the ssc of the isth. J Thromb Haemost 2009; 7: 1029.
   PubMed Web of Science ®Google Scholar
• Von Kaulla KN, Swan H. Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant. J Thorac Surg 1958; 36: 519–530.
   Google Scholar
• Ingram GI, Mann CV. The defibrination syndrome arising during mitral valvotomy. Istanbul Tip Fak Mecmuasi 1959; 14: 236–237.
   Google Scholar
• Nilsson IM, Sjoerdsma A, Waldenstrom J. Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man. Lancet 1960; 1: 1322–1326.
   PubMedGoogle Scholar
• Gans H, Krivit W. Problems in hemostasis during openheart surgery. Iii. Epsilon amino caproic acid as an inhibitor of plasminogen activator activity. Ann Surg 1962; 155: 268–276.
   Google Scholar
• Gans H, Castaneda AR, Subramanian V, John S, Lillehei CW. Problems in hemostasis during open heart surgery. Ix. Changes observed in the plasminogen-plasmin system and their significance for therapy. Ann Surg 1967; 166: 980–986.
   Google Scholar
• Porter JM, Silver D. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1968; 56: 869–878.
   Google Scholar
• Gans H, Lillehei CW, Krivit W. Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator. Ann Surg 1961; 154: 915–924.
   Google Scholar
• Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383–392.
   PubMed Web of Science ®Google Scholar
• Astrup T. Fibrinolysis in the organism. Blood 1956; 11: 781–806.
   PubMed Web of Science ®Google Scholar
• Von Kaulla KN. Continuous automatic recording of fibrin formation and fibrinolysis: a valuable tool for coagulation research. J Lab Clin Med 1957; 49: 304–312.
   Google Scholar
• Umlas J. Fibrinolysis and disseminated intravascular coagulation in open heart surgery. Transfusion 1976; 16: 460–463.
   PubMedGoogle Scholar
• Yoon SH, Cho YS, Park CY, Chung CH. Disseminated intravascular coagulation associated with aortic dissecting aneurysm. Korean J Intern Med 2004; 19: 134–136.
   Google Scholar
• Ferraris VA, Ferraris SP, Saha SP, Hessel EA2d, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83(5 Suppl): S27–S86.
   Google Scholar
• Despotis G, Eby C, Lublin DM. A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 2008; 48(1 Suppl): S2–S30.
   Google Scholar
• Simon TL, Akl BF, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 1984; 37: 359–364.
   PubMedGoogle Scholar
• Taneja R, Fernandes P, Marwaha G, Cheng D, Bainbridge D. Perioperative coagulation management and blood conservation in cardiac surgery: a canadian survey. J Cardiothorac Vasc Anesth 2008; 22: 662–669.
   Google Scholar
• Despotis GJ, Grishaber JE, Goodnough LT. The effect of an intraoperative treatment algorithm on physicians’ transfusion practice in cardiac surgery. Transfusion 1994; 34: 290–296.
   PubMed Web of Science ®Google Scholar
• Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69–73.
   PubMed Web of Science ®Google Scholar
• Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365–368.
   Google Scholar
• Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate—a potential universal hemostatic agent. Expert Opin Biol Ther 2009; 9: 1325–1333.
   PubMed Web of Science ®Google Scholar
• Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834–843.
   PubMed Web of Science ®Google Scholar
• Yasunaga H. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in japan. Lancet 2007; 370: 2063–2067.
   PubMed Web of Science ®Google Scholar
• Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21–27.
   Google Scholar
• Cattaneo M. The use of desmopressin in open-heart surgery. Haemophilia 2008; 14(Suppl) 1: S40–S47.
   Google Scholar
• Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jambor C. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesth Analg 2010; 110: 702–707.
   PubMed Web of Science ®Google Scholar
• Henke P, Froehlich JB, Upchurch G, Jr., Wakefield T. The significant negative impact of in-hospital venous thromboembolism after cardiovascular procedures. Ann Vasc Surg 2007; 21: 545–550.
   Google Scholar
• Oliveira DC, Fero CR, Oliveira JB, Malta MM, Barros Neto P, Cano SJ, Martins SK, Zouze LC, Jatene AD, Piegas LS. Risk factors for stroke after coronary artery bypass grafting. Arq Bras Cardiol 2008; 91: 213–216.
   Google Scholar
• Loponen P, Taskinen P, Laakkonen E, Nissinen J, Luther M, Wistbacka JO. Perioperative stroke in coronary artery bypass patients. Scand J Surg 2003; 92: 148–155.
   Google Scholar
• Baker RA, Stump DA. Embolic events. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, Eds. Cardiopulmonary Bypass Principles and Practice. Third Ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins, 2008: 261–281.
   Google Scholar
• Edmunds LH. Cardiopulmonary bypass after 50 years. N Engl J Med. 2004;351(16):1603–1606.
   Google Scholar
• Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 1989; 97: 379–388.
   PubMed Web of Science ®Google Scholar